DAIC

APRIL 22, 2024

(RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24 This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg.

Technology 105

Technology Biomarkers Heart Attack Heart attacks 105

DAIC

JUNE 4, 2024

Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heart attack risk.

Technology 116

Technology Heart Attack Heart attacks Coronary Artery Disease 116

DAIC

JULY 10, 2024

mtaschetta-millane Wed, 07/10/2024 - 09:02 July 10, 2024 — CellProthera , a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia, Inc. , The ProtheraCytes, which are autologous, expanded CD34+ stem cells, were well tolerated with no unexpected serious adverse events reported.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Heart Attack Heart attacks 105

DAIC

APRIL 9, 2024

Although they had no symptoms of heart failure or blockages in arteries carrying blood to the heart, they all had structural heart disease or abnormal cardiac biomarkers that classified them as having “pre-heart failure,” putting them at high risk for developing overt symptoms of the diagnosis.

Heart Failure 52

Heart Failure Diabetes Cardiomyopathy Exercise 52

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. vs. 13.2%, respectively).

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

JANUARY 23, 2024

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 milligrams per liter (mg/L) are linked to increased risk of heart attacks or risk of a repeat heart attack.23 4 In the U.S.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

DAIC

JANUARY 30, 2024

Clinicians currently use two separate risk models to assess patients’ chances of having heart attacks , strokes , and other major cardiovascular events. The ARIC participants included some cases with established atherosclerotic cardiovascular disease and some without.

Cardiovascular Disease 52

Cardiovascular Disease Research Heart Attack Heart attacks 52